Brief Research Report
Gallbladder mucocele (GBM) has been reported with increased frequency in dogs since 2004 (19 articles listed in PubMed) compared to the period from 1994 to 2003 (4 arti cles listed in PubMed). While the etiology of GBM has not yet been identified, a previous study has linked GBM in dogs to specific endocrine diseases, 7 while another has identified an association with a mutation in the canine ABCB4 (adeno sine triphosphatebinding cassette, subfamily B, member 4) gene. 6 A strong association between hypercortisolism and/or hypothyroidism and GBM has been identified. Specifically, the odds of a dog having a GBM were 29 times and 3 times, respectively, that of dogs without those endocrinopathies. 7 An insertion mutation in the canine ABCB4 gene (ABCB4 1583_1584G) has also been associated with GBM in a small number of dogs, primarily Shetland Sheepdogs. 2 Each of the factors that have been associated with GBM in dogs (hyper cortisolism, hypothyroidism, and ABCB4 mutation) can be linked to abnormal bile composition and/or flow. In human beings, hypercortisolism has been shown to decrease bile flow and alter bile composition resulting in excessive choles terol and a relative deficiency of phospholipids and cholic acid. 4 Hypothyroidism in rats has been shown to decrease both bile flow and bile salt excretion by 50%. 10 Functional ABCB4 mutations in human beings cause abnormalities in bile flow and composition that result in a variety of hepato biliary diseases, 2,3,5 but GBM is not among them. Whereas hepatobiliary disease-causing ABCB4 mutations are well characterized in human beings, the authors are aware of only 1 study involving ABCB4 dysfunction and hepatobiliary dis ease in dogs. 6 Thus, the objective of the current study was to determine if ABCB4 1583_1584G, the mutation previously associated with GBM in Shetland Sheepdogs is present in a wider sample of dogs with GBM compared with age and breedmatched controls without GBM.
Cases were selected by searching the electronic database at North Carolina State University (Raleigh, North Carolina) for dogs with a diagnosis of GBM. 8 The search yielded 46 dogs (either biopsy or necropsy cases) including 8 Shetland Sheepdogs, spanning the years 2004-2010. The next search was for breed and agematched dogs without a diagnosis of GBM at necropsy. Age matching was performed as closely as possible and generally resulted in dogs of the same breed with an age within 2 years of those with GBM. Additional dogs, beyond those necessary for breed and age matching, were also used for Shetland Sheepdogs (n = 12) and other breeds (n = 48) to analyze the presence of gene mutations in dogs without GBM, for a total of 60 unaffected dogs. Addi tional dogs were included because it was anticipated that the quality or quantity of DNA obtained from some formalin fixed, paraffinembedded samples might not be adequate for sequencing. The final number of sequenced DNA samples included 36 dogs with GBM and 49 control dogs. Abstract. The etiology of canine gallbladder mucocele (GBM) has not yet been identified. However, several studies have linked GBM in dogs to particular breeds (Shetland Sheepdogs are commonly implicated), concurrent endocrine disease (hyperadrenocorticism and/or hypothyroidism), and a mutation in the canine ABCB4 gene (ABCB4 1583_1584G), particularly in Shetland Sheepdogs. The current study assessed ABCB4 1583_1584G, in a wider sample of dogs with GBM compared with age and breedmatched controls. ABCB4 1583_1584G was identified in 4 of 8 Shetland Sheepdogs and 13 of 28 other breeds with GBM. ABCB4 1583_1584G was also detected in 9 of 12 Shetland Sheepdogs and 23 of 37 other breeds that did not have GBM. No statistically significant association existed between ABCB4 1583_1584G and the presence of GBM for all dogs combined or for Shetland Sheepdogs alone. In contrast to previously reported findings, the current study did not identify a strong association between ABCB4 1583_1584G and GBM in Shetland Sheepdogs or other breeds.
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Formalinfixed, paraffinembedded liver tissue samples were processed using a commercial RNA extraction kit a until step C3. The interphase from this step (containing DNA and protein) was then subjected to DNA extraction using a com mercial kit. b Exon 12 of canine ABCB4 was amplified with the following primers: 5′GAGATACATCAGGAGCTCCTCC3′ and 5′CAGGTGTTTCGGGTTGACTG3′. Purified PCR amplicons were then sequenced. c Proc FREQ in SAS d was used to perform the statistical analysis of the ABCB4 insertion mutation and GBM data. Due to the small number of counts in each of the cells in the frequency tables, Fisher exact test was used to determine whether an association existed between ABCB4 1583_1584G and GBM. The odds ratio was also calculated to determine if an association existed between dogs with the ABCB4 muta tion and GBM. The analysis was performed for all dogs, and then separately for the Shetland Sheepdogs because previous studies have indicated that this breed is predisposed to GBM. All tests were performed at the 5% level of statistical signifi cance unless otherwise noted.
Gallbladder mucocele was diagnosed on the basis of appropriate gross appearance (pigmented, tenacious, and rubbery contents) at the time of surgery or by evaluation by pathologists and histologic confirmation (proliferation of gall bladder mucosa with prominent projections of epithe lium into the mucus) at biopsy or postmortem for all cases. 9 The gallbladder was ruptured or had mural necrosis and/or infarction in 12 of 36 (33.3%) cases. Fibrosis of the gallblad der was observed in 2 of 36 (5.6%) cases. Gallbladder epi thelial hyperplasia and cholecystitis were present in 4 of 36 (11.1%) and 1 of 36 (2.8%) cases, respectively, with a GBM. For the comparison group, only postmortem specimens were evaluated, and the absence of GBM was confirmed by histo logic review and examination of gall bladder contents.
Liver samples were analyzed from 36 dogs with GBM and 49 dogs without GBM (Supplemental Tables 1, 2 ). Eight Shetland Sheepdogs (age range: 4-12 years, median age: 10) and 28 dogs of other breeds (age range: 5-14 years, median age: 10) with GBM were included while control dogs con sisted of 12 Shetland Sheepdogs (age range: 3-13 years, median age: 10) and 37 dogs (age range: 1-19 years, median age: 10) of similar breeds to those with GBM. Shetland Sheepdogs comprised 22% of GBM cases (8 of 36). Other breeds with more than 1 dog with a GBM included the Cocker Spaniel (5), Beagle (2), Bichon Frise (2), Chihuahua (2), Dachshund (2), Labrador Retriever (2), Miniature Pin scher (2), and Miniature Schnauzer (2) .
The presence of ABCB4 1583_1584G or the wildtype canine ABCB4 sequence was determined for all 85 dogs using DNA extracted from formalinfixed, paraffinembed ded liver biopsies ( Table 1 ). The overall genotype distribu tion was 42.4% for the homozygous ABCB4 wildtype allele and 57.6% for ABCB4 1583_1584G heterozygotes. ABCB4 1583_1584 was identified in 4 of 8 Shetland Sheepdogs with GBM and 9 of 12 Shetland Sheepdogs without GBM. For other breeds, ABCB4 1583_1584 was identified in 13 of 28 dogs with GBM and 23 of 37 dogs without GBM.
The statistical analysis used to determine if an association existed between the mutation and GBM data showed no sta tistically significant differences for all dogs combined or for Shetland Sheepdogs. The Fisher exact test pvalues were greater than 0.05, and the 95% confidence limits for the odds ratios included 1 (odds ratios of 1 indicate no association).
The canine ABCB4 insertion mutation ABCB4 1583_1584G has previously been reported to be associated with GBM in dogs, particularly Shetland Sheepdogs. 2 Results of the current study, which are discordant from the previous study, are that ABCB4 1583_1584G is not associ ated with GBM.
The discordance of results between the original study and the current one may be due to several factors, including the potential for falsenegative "control" dogs due to the fact that GBM is a disease of older animals, the lack of a gold stan dard method for diagnosing GBM, and the potential for a greater degree of relatedness among Shetland Sheepdogs in the original study. Mutations causing dysfunction of ABCB4 in human patients result in a variety of hepatobiliary dis eases. The unaffected population of dogs in the original study included only dogs with no evidence of hepatobiliary disease based on normal serum biochemical panels. In con trast, several of the control dogs in the current study had his tologic findings of periportal or bridging fibrosis, cholangitis, and/or biliary hyperplasia. These are hepatic abnormalities frequently observed in human patients with ABCB4 muta tions. It is conceivable that hepatobiliary disease in some of these dogs may have eventually progressed to GBM. Addi tionally, GBM tends to occur in older animals (mean: 9-10 years of age). 1, 68 Because 13 of 49 of the "unaffected" dogs were less than 7 years of age, they might also represent false negatives thereby contributing to the discordant results of the 2 studies. Lack of a gold standard method for diagnosing GBM, particularly developing GBM, may also be a contributing factor. Inclusion criteria for affected dogs in the original study consist of surgical diagnosis, ultrasonographic diag nosis, or necropsy/histologic diagnosis. 9 In contrast, inclu sion criteria for dogs in the current study consisted strictly of a necropsy diagnosis of GBM with histologic confirma tion. Limitations of each of these criteria for diagnosing GBM have been discussed previously. 6 Whether or not each of these diagnostic methods perform comparably in accurately diagnosing GBM has not been investigated. Thus, the affected population in both studies might include false positives and the unaffected population might contain false negatives. Another source of false negatives in the current study may be that dogs with ABCB4 1583_1584G could have eventually developed GBM had they not died of other causes first.
Lastly, it is possible that there was a higher degree of relatedness, particularly among Shetland Sheepdogs, in the original study compared to the current one. Because affected dogs were solicited through the American Shetland Sheep dog Association in that study, it is reasonable to suspect that wordofmouth recruitment occurred among owners of related dogs. In fact, a sibling pair of affected Shetland Sheepdogs was identified in the initial study. In the current study, owners and breeders were not solicited. Rather, the patient population was selected from submissions to a par ticular hospital, which may be less likely to include related dogs.
Hyperadrenocorticism and hypothyroidism have been reported to be significantly associated with the diagnosis of GBM in dogs. 7 Both hyperadrenocorticism and hypothy roidism are considered common endocrinopathies in dogs whereas GBM occurs much less commonly, suggesting that these are relative, not absolute, risk factors for GBM for mation. The findings in the current study do not rule out the possibility that ABCB4 1583_1584G may also be one of many relative risk factors for GBM in dogs.
In conclusion, the present study brings into question the association of ABCB41583_1584G with GBM in dogs. How ever, it does not rule out the possibility that the etiology of GBM in dogs is multifactorial and that ABCB4 dysfunction may be one of many contributing factors. What this study does make clear is that clinical use of a genetic test for ABCB4 1583_1584G is premature and would not yet provide useful diagnostic information for veterinarians. It would also not provide dog breeders with information necessary to make informed breeding decisions.
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